1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-54. [DOI via Crossref] [Pubmed] | | 2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10. [DOI via Crossref] [Pubmed] | | 3. Hansson LO, Lindquist L. C-reactive protein: its role in the diagnosis and follow-up of infectious diseases. Curr Opin Infect Dis. 1997;10:196-201. [DOI via Crossref] | | 4. Lehrnbecher T, Venzon D, de Haas M, Chanock SJ, Kuehl J. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis. 1999;29:414-9. [DOI via Crossref] [Pubmed] | | 5. Katz JA, Mustafa MM, Bash RO, Cash JV, Buchanan GR. Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatr Infect Dis J. 1992;11:708-12. [DOI via Crossref] [Pubmed] | | 6. Engel A, Mack E, Kern P, Kern WV. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteraemia and complicated infection in neutropenic cancer patients. Infection. 1998;26:213-21. [DOI via Crossref] [Pubmed] | | 7. Farag NA, Taema KM, Abdel-Latiff E, Hamed G. Differentiating sepsis from non-infective systemic inflammatory response syndrome: comparison between C-reactive protein and Leptin. Egypt J Crit Care Med. 2013;1(3):111-118. [DOI via Crossref] | | 8. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138-50. [DOI via Crossref] [Pubmed] | | 9. Gullo A, Bianco N, Berlot G. Management of severe sepsis and septic shock: challenges and recommendations. Crit Care Clin. 2006; 22(3):489-501. [DOI via Crossref] [Pubmed] | | 10. Zambon M, Ceola M, Almeida-de-Castro R, Gullo A, Vincent JL. Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster. J Crit Care. 2008;23(4):455-60. [DOI via Crossref] [Pubmed] | | 11. Chan Y, Liao H, Tsay P, Chang S, Chen J, Liaw S. C-reactive protein as n indicator of bacterial infection of adult patients in the emergency department. Chang Gung Med J. 2002;25(7):437-44. [Pubmed] | | 12. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med. 1999;27:498-504. [DOI via Crossref] [Pubmed] | | 13. Suprin E, Camus C, Gacouin A, Le Tulzo Y, Lavoue S, Feuillu A, et al. Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med. 2000;26:1232-8. [DOI via Crossref] [Pubmed] | | 14. Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000; 28:977-83. [DOI via Crossref] [Pubmed] | |
|
|